Provention Bio, Inc.
PRVBNASDAQHealthcare
$24.98
+$0.00(+0.00%)
Market Cap$2.4B
P/E Ratio—
52W High$25.0
52W Low$3.185
Provention Bio, Inc. (PRVB) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · PRVB · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2022-12 | 2021-12 | 2020-12 | 2019-12 | 2018-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $12.89M | $1.40M | $0.00M | $0.00M | $0.00M |
| Cost of Revenue | $0.51M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $12.38M | $1.40M | $0.00M | $0.00M | $0.00M |
| Gross Margin %(computed) | 96.03% | 100.00% | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $75.80M | $69.63M | $66.36M | $36.36M | $22.65M |
| G&A Expenses | $64.11M | $47.35M | $33.33M | $8.01M | $4.17M |
| Total Operating Expenses | $140.54M | $116.97M | $99.69M | $44.37M | $26.81M |
| Operating Income | ($128.16M) | ($115.58M) | ($99.69M) | ($44.37M) | ($26.81M) |
| Operating Margin %(computed) | -993.88% | — | — | — | — |
| Interest Income | $2.24M | $0.15M | $0.58M | $1.09M | $0.67M |
| Interest Expense | $1.04M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($126.96M) | ($115.43M) | ($99.10M) | ($43.28M) | ($26.66M) |
| Income Tax Expense | ($13.39M) | ($1.00M) | ($0.52M) | ($1.09M) | ($0.19M) |
| Net Income | ($113.56M) | ($114.43M) | ($98.58M) | ($42.20M) | ($26.48M) |
| Net Margin %(computed) | -880.69% | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.52 | $-1.81 | $-1.88 | $-1.04 | $-1.18 |
| Wtd Avg Shares | 74.72M | 63.10M | 52.46M | 40.75M | 22.44M |
| EBITDA | ($124.69M) | ($115.19M) | ($99.65M) | ($44.37M) | ($26.66M) |
| EBITDA Margin %(computed) | -966.98% | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Provention Bio, Inc. data
About Provention Bio, Inc. (PRVB) Income Statement
Provention Bio, Inc. (PRVB) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2022, PRVB reported revenue of $0.01B, gross profit of $0.01B (gross margin 96.03%), and net income of ($0.11B) — a net profit margin of -880.69%.
Frequently asked questions
PRVB · 4 questionsProvention Bio, Inc. (PRVB) reported revenue of $0.01B for 2022, up 824.4% year-over-year.
PRVB revenuePRVB salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08